𝐆𝐥𝐨𝐛𝐚𝐥 𝐂𝐀𝐑-𝐓 𝐂𝐞𝐥𝐥 𝐓𝐡𝐞𝐫𝐚𝐩𝐲 𝐌𝐚𝐫𝐤𝐞𝐭
The global CAR-T cell (Chimeric Antigen Receptor-T Cell Therapy) market was valued at USD 5.2 billion in 2024 and is projected to reach USD 26.2 billion by 2030. The market is expected to grow at a CAGR of 31% during the forecast period, 2025-2030. 𝐂𝐀𝐑-𝐓 𝐂𝐞𝐥𝐥 𝐓𝐡𝐞𝐫𝐚𝐩𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐋𝐢𝐧𝐤: https://www.wissenresearch.com/car-t-cell-therapy-market/ 𝐏𝐫𝐨𝐦𝐢𝐧𝐞𝐧𝐭 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 𝐖𝐢𝐭𝐡𝐢𝐧 𝐂𝐀𝐑-𝐓 𝐂𝐞𝐥𝐥 𝐓𝐡𝐞𝐫𝐚𝐩𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 • Bristol-Myers Squibb Company (US) • Novartis AG (Switzerland) • Gilead Sciences, Inc. (US) • Johnson & Johnson. (US) • JW Therapeutics (Shanghai) Co., Ltd. (China) • bluebird bio, Inc. (US) • Merck & Co., Inc. (US) • Sangamo Therapeutics (US) • Sorrento Therapeutics, Inc. (US) • GSK plc. (UK) • ImmunoACT Pvt Ltd (India) • CARsgen Therapeutics Holdings Ltd. (China) • IASO Biotherapeutics. (China) 𝐀𝐬𝐤 𝐟𝐨𝐫 𝐜𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐞𝐝 𝐫𝐞𝐩𝐨𝐫𝐭: https://www.wissenresearch.com/ask-for-customization/














